| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581775 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 8 Pages |
Abstract
Although median TFS of 11q- patients in this cohort was short at 2.5 years, OS remains long at 14.7 years, even when most patients received initial treatment without alkylators.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Jennifer Goy, Tanya L. Gillan, Helene Bruyere, Steven J.T. Huang, Monica Hrynchak, Aly Karsan, Khaled Ramadan, Joseph Connors, Cynthia L. Toze, Alina S. Gerrie,